Exactitude Consultancy
Home Report Store Categories Primary Research Consulting Services Blog Contact us About Us Terms & Conditions Privacy Policy

Needle-Free Injection System Market

May 2022

Base Year Value ()

x.x %
x.x %

CAGR ()

x.x %
x.x %

Forecast Year Value ()

x.x %
x.x %

Historical Data Period

Largest Region

Forecast Period

ニードルフリー注射システム市場:技術別(ジェット、スプリング、マイクロアレイパッチ)、製品別(プレフィルド、充填可能)、薬剤タイプ別(液体、粉末)、用途別(ワクチン接種、皮膚科)、エンドユーザー別(病院、在宅ケア)、地域別(アジア太平洋、北米、ヨーロッパ、南米、中東、アフリカ) - 2022年から2029年までの世界予測

Instant access to hundreds of data points and trends

  • Market estimates from 2014-2029
  • Competitive analysis, industry segmentation, financial benchmarks
  • Incorporates SWOT, Porter's Five Forces and risk management frameworks
  • PDF report or online database with Word, Excel and PowerPoint export options
  • 100% money back guarantee

無針注射システム市場の概要


世界の無針注射システム市場規模は2020年に1億580万米ドルで、2029年までに4億6074万米ドルまで成長し、年平均成長率(CAGR)は17.90%になると予想されています。

針なし注射器は、薬剤の準備、針の挿入、針の取り扱いと廃棄の必要性など、従来の注入および注射方法に関連するリスクを軽減することで、患者と医療従事者の両方に高い安全性を提供します。米国看護師協会によると、偶発的な針刺し傷害の約 74.0% は汚染が原因であり、感染の可能性が高まり、多額の治療費につながる可能性があります。






























































属性詳細
研究期間2020-2029
基準年2021
推定年2022
予測年2022-2029
歴史的時代2018-2020
ユニット価値(百万米ドル)
セグメンテーション技術別、製品別、医薬品の種類別、用途別、最終用途産業別、地域別
テクノロジー別

  • ジェット


  • マイクロアレイパッチ

  • 他の


製品別

薬の種類別

  • 液体



アプリケーション別

  • 予防接種

  • 皮膚科


最終用途産業別

  • 病院

  • ホームケア


地域別

  • 北米

  • ヨーロッパ

  • アジア太平洋

  • 外務省

  • ラテンアメリカ



米国疾病予防管理センター (CDC) は、針刺し事故の治療費は 1 件あたり 500 ~ 3,000 ドルと見積もっており、感染症の場合はさらに高額になります。CDC は、米国の病院で年間 385,000 件の針刺し事故が発生すると予測しており、欧州労働安全衛生機関は、世界中で毎年約 100 万件の針刺し事故が発生していると報告しています。


医療費の高騰は、費用対効果の高い高品質の医療を提供しようと努力する発展途上国と先進国の両方にとって大きな課題となっています。医療費の補助金や保険プログラムがあるにもかかわらず、米国の医療費は着実に上昇し続けており、医療提供者の間で懸念を引き起こしています。米国の医療費は世界平均の 2.4 倍を超えており、今後 10 年間で 68.0% 増加すると予測されています。針なし注射器の導入により、患者は自宅で快適に皮下注射薬を自己投与できるようになり、病院への通院やその他の医療施設でのやり取りの頻度が減る可能性があります。このアプローチは、患者が医療費を効果的に管理し、最小限に抑えるのに役立つと期待されています。




[キャプション id="attachment_9618" align="alignleft" width="870"]Needle-Free Injection System Market | Exactitude Consultancy
無針注射システム市場 | Exactitude Consultancy
[/キャプション]

Frequently Asked Questions

• What is the Size of global Needle-Free Injection System market?

The Needle-Free Injection System market size had crossed USD 105.80 million in 2020 and is expected to grow till USD 460.74 million by 2029.

• Which is the largest regional market for Needle-Free Injection System market?

The Largest Regional market for Needle-Free Injection System market is North America having a market share of 58%.

• What is the CAGR of Needle-Free Injection System market?

The global Needle-Free Injection System market registered a CAGR of 17.90% from 2022 to 2029.

• Which are the top companies to hold the market share in Needle-Free Injection System market?

Key players profiled in the report include PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

• What are the main industries that Needle-Free Injection System are used in?

Hospital, Homecare, and other sectors are among Needle-Free Injection System' key end-use industries.

• What are the factors Driving the growth of Needle-Free Injection System?

Technological Advancement and Increasing demand for self-injection devices to drive the Needle-Free Injection System Market

Needle-Free Injection System Market Segment Analysis

The Needle-Free Injection System market is segmented by Technology, Product, Type of Medication, Application, End Users.

On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.

On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.

On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.

On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.

[caption id="attachment_9587" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]
Needle-Free Injection System Market Players

The Key Players in Needle-Free Injection System Market are PharmaJet, Portal Instruments, Medical International Technology, Inc (MIT), NuGen Medical Devices, Crossject SA, and Bioject Medical Technologies.

Market leaders are putting a premium on new product releases, as well as other organic growth methods like patents and events. Acquisitions, as well as partnerships and collaborations, were considered inorganic growth tactics in the market. As a consequence of these efforts, market participants may now be able to expand their business and client base. In the future, industry participants in the needle-free injection system market are projected to benefit from excellent development opportunities.

Who Should Buy? Or Key Stakeholders

  • Industry and consulting firms
  • State and national regulatory authorities
  • Investors
  • Suppliers and Distributors
  • Research Institutes
  • Others

Key Takeaways:

  • The global Needle-Free Injection System market is expected to grow at a Compound annual growth rate (CAGR) of 17.90%.
  • On the basis of Technology, global Needle-Free Injection System market is segmented into Jet, Spring, Micro-array Patch.
  • On the basis of Type of Medication, global Needle-Free Injection System market is segmented into Prefilled, Fillable.
  • On the basis of Application, global Needle-Free Injection System market is segmented into Liquid, Powder.
  • On the basis of End Users, global Needle-Free Injection System market is segmented into Hospital, Homecare.
  • North America led the needle-free injection market with a 58 percent share.
  • The major trend in the Needle-Free Injection System Market is the growing demand for painless drug delivery methods.

Needle-Free Injection System Market Regional Analysis

Geographically, Needle-Free Injection System market is segmented into North America, Europe, Asia Pacific, and Rest of the world.

  • North America: includes the US, Canada, Mexico
  • Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
  • Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC

North America led the needle-free injection market with a 58 percent share, followed by Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa. During the projected period, however, the APAC region is predicted to develop at the fastest rate. The rapidly developing healthcare industries in China and India, rising life expectancy, rising per capita income, increasing investments in the region by key market players, the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing, the presence of a favorable regulatory environment, and growing demand for self-injectable device testing are all driving market growth in the APAC region.

[caption id="attachment_9633" align="alignleft" width="680"]Needle-Free Injection System Market | Exactitude Consultancy
Needle-Free Injection System Market | Exactitude Consultancy
[/caption]

Key Market Segments: Needle-Free Injection System Market

Needle-Free Injection System Market by Technology, 2020-2029 (USD Millions)
  • Jet
  • Spring
  • Micro-Array Patch
  • Other
Needle-Free Injection System Market by Product, 2020-2029 (USD Millions)
  • Prefilled
  • Fillable
Needle-Free Injection System Market by Type of Medication, 2020-2029 (USD Millions)
  • Liquid
  • Powder
Needle-Free Injection System Market by Application, 2020-2029 (USD Millions)
  • Vaccination
  • Dermatology
Needle-Free Injection System Market by End Use Industry, 2020-2029 (USD Millions)
  • Hospital
  • Homecare
Needle-Free Injection System Market by Region, 2020-2029 (USD Millions)
  • North America
  • Europe
  • APAC
  • MEA
  • Latin America
Important Countries In All Regions Are Covered.

Objectives of the Study

  • To provide an overall view of the market.
  • To detail out key pointers such as growth, market size, trends, drivers, restraints, challenges and opportunities in quantitative and qualitative terms
  • To provide a holistic view of market players and their activities to get an understanding of key growth strategies adopted

Key Question Answered

  • What is the current market size of this high growth market?
  • What is the overall growth rate?
  • What are the key growth areas, applications, end uses and types?
  • Key reasons for growth
  • Challenges for growth
  • What technological developments are happening in this area?

  1. 導入

    1. 市場の定義

    2. 市場セグメンテーション

    3. 研究タイムライン

    4. 前提と制限



  2. 研究方法

    1. データマイニング

      1. 二次調査

      2. 一次研究

      3. 専門家のアドバイス



    2. 品質チェック

      1. 最終レビュー



    3. データの三角測量

      1. ボトムアップアプローチ

      2. トップダウンアプローチ

      3. 研究の流れ



    4. データソース



  3. エグゼクティブサマリー

  4. 市場概要

    1. 世界の無針注射システム市場の見通し

      1. 市場の推進要因

      2. 市場の制約

      3. 市場機会



    2. 新型コロナウイルスによる無針注射システム市場への影響

    3. ポーターの5つの力タイプ

      1. 新規参入者からの脅威

      2. 代替品からの脅威

      3. サプライヤーの交渉力

      4. 顧客の交渉力

      5. 競争の度合い



    4. 業界バリューチェーン分析



  5. 技術別世界の無針注射システム市場

    1. ジェット


    2. マイクロアレイパッチ

    3. 他の



  6. 製品別世界の無針注射システム市場

    1. 事前入力済み

    2. 記入可能



  7. 薬剤の種類別世界無針注射システム市場

    1. 液体




  8. 用途別世界無針注射システム市場

    1. 予防接種

    2. 皮膚科



  9. 最終用途産業別世界の無針注射システム市場

    1. 病院

    2. ホームケア



  10. 地域別世界無針注射システム市場

    1. 北米

      1. 私たち

      2. カナダ

      3. メキシコ



    2. 南アメリカ

      1. ブラジル

      2. アルゼンチン

      3. コロンビア

      4. 南米のその他の地域



    3. ヨーロッパ

      1. ドイツ

      2. 英国

      3. フランス

      4. イタリア

      5. スペイン

      6. ロシア

      7. その他のヨーロッパ



    4. アジア太平洋

      1. インド

      2. 中国

      3. 日本

      4. 韓国

      5. オーストラリア

      6. 東南アジア

      7. その他のアジア太平洋地域



    5. 中東およびアフリカ

      1. アラブ首長国連邦

      2. サウジアラビア

      3. 南アフリカ

      4. その他の中東およびアフリカ







  1. 会社概要*(事業概要、会社概要、提供製品、最近の動向)



  1. ファーマジェット

  2. ポータル機器

  3. メディカルインターナショナルテクノロジー社(MIT)

  4. ニュージェン医療機器

  5. Crossject SA Bioject Medical Technologies  *企業リストは参考です


 

表のリスト


TABLE 1           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 2           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 3           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 4           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 5           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 6           GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (USD MILLIONS) 2020-2029

TABLE 7           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 8           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 9           US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 10        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 11        US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 12        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 13        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 14        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 15        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 16        CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 17        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 18        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 19        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 20        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 21        MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 22        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 23        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 24        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 25        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 26        BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 27        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 28        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 29        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 30        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 31        ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 32        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 33        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 34        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 35        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 36        COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 37        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 38        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 39        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 40        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 41        REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 42        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 43        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 44        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 45        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 46        INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 47        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 48        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 49        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 50        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 51        CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 52        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 53        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 54        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 55        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 56        JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 57        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 58        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 59        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 60        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 61        SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 62        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 63        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 64        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 65        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 66        AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 67        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 68        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 69        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 70        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 71        SOUTH-EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 72        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 73        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 74        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 75        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 76        REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 77        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 78        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 79        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 80        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 81        GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 82        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 83        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 84        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 85        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 86        UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 87        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 88        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 89        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 90        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 91        FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 92        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 93        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 94        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 95        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 96        ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 97        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 98        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 99        SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 100      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 101      SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 102      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 103      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 104      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 105      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 106      RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 107      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 108      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 109      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 110      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 111      REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 112      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 113      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 114      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 115      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 116      UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 117      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 118      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 119      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 120      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 121      SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 122      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 123      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 124      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 125      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 126      SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

TABLE 127      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029

TABLE 128      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD MILLIONS) 2020-2029

TABLE 129      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF MEDICATION (USD MILLIONS) 2020-2029

TABLE 130      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY APPLICATION (USD MILLIONS) 2020-2029

TABLE 131      REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD MILLIONS) 2020-2029

 

LIST OF FIGURES


FIGURE 1              MARKET DYNAMICS

FIGURE 2              MARKET SEGMENTATION

FIGURE 3              REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4              DATA TRIANGULATION

FIGURE 5              BOTTOM-UP APPROACH

FIGURE 6              TOP-DOWN APPROACH

FIGURE 7              RESEARCH FLOW

FIGURE 8        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 9        GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY PRODUCT USD MILLION, 2020-2029

FIGURE 10     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TYPE OF MEDICATIONR, USD MILLION, 2020-2029

FIGURE 11     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY TECHNOLOGY, USD MILLION, 2020-2029

FIGURE 13     GLOBAL NEEDLE-FREE INJECTION SYSTEM MARKET BY REGION, USD MILLION, 2020-2029

FIGURE 12     PORTER’S FIVE FORCES TYPE

FIGURE 13     NORTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 14     EUROPE NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 15     ASIA PACIFIC NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 16           SOUTH AMERICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 17           MIDDLE EAST & AFRICA NEEDLE-FREE INJECTION SYSTEM MARKET SNAPSHOT

FIGURE 18           PHARMAJETCOMPANY SNAPSHOT

FIGURE 19           PORTAL INSTRUMENTSCOMPANY SNAPSHOT

FIGURE 20           MEDICAL INTERNATIONAL TECHNOLOGY, INC (MIT)COMPANY SNAPSHOT

FIGURE 21           NUGEN MEDICAL DEVICESCOMPANY SNAPSHOT

FIGURE 22           CROSSJECT SA BIOJECT MEDICAL TECHNOLOGIESCOMPANY SNAPSHOT

DOWNLOAD FREE SAMPLE REPORT

Kindly share your specific requirement (if any)
7800

License Type

Single User

US$ 3499

Multi User

US$ 4499

Corporate User

US$ 5499

Get Sample to Email

SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

WANT TO CUSTOMIZE THE REPORT?

Our Clients Speak

We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te

Yosuke Mitsui

Senior Associate Construction Equipment Sales & Marketing

Why choose us

Proactive

We manage our resources 24/7 to identify issues and address them before they become problems

Quality & Reliability

We are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach

6 Major regions and 40+ countries level analysis accomplished

Competitive Pricing

Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

In-Depth Database

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Customer Support

Complete pre and post sales support.

Safe & Secure

Safe & Secure

Complete secure payment process.